Transitional cell carcinoma of the bladder in four patients on maintenance hemodialysis.

We report four patients on maintenance hemodialysis (HD) with transitional cell carcinoma (TCC) of the bladder. Three patients underwent transurethral resection (TUR) of their tumors, which were grade 2 or 3, stage pT1 TCC. Among them, one patient underwent repeat TUR for recurrent superficial TCC. The remaining one patient underwent total cystectomy for grade 3, stage pT4 TCC and squamous cell carcinoma of the bladder. Subsequently, he died suddenly without evidence of local recurrence or systemic metastasis. We discuss the relationship between the duration of HD and the tumor grade and stage of primary bladder TCC in maintenance HD patients.

[1]  P. Boyle,et al.  Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. , 2003, Journal of the American Society of Nephrology : JASN.

[2]  T. Uchida,et al.  Six cases of bladder cancer patients with end-stage renal disease , 2002 .

[3]  K. Naito,et al.  A case of intravesical BCG instillation for bladder cancer in a patient receiving hemodialysis , 2002 .

[4]  A. Heidland,et al.  Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  T. Saika,et al.  Bladder cancer in a hemodialysis patient -A case report- , 1998 .

[6]  J. Witjes,et al.  Bacille Calmette-Guérin in superficial transitional cell carcinoma. , 1998, British journal of urology.

[7]  F. Ito,et al.  Bladder tumors in chronic hemodialysis patients , 1998 .

[8]  A. Heidland,et al.  Cancer in End-Stage Renal Disease: Potential Factors Involved , 1998, American Journal of Nephrology.

[9]  S. Chu,et al.  Urologic cancers in uremic patients. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  R. Cote,et al.  Two molecular pathways to transitional cell carcinoma of the bladder. , 1994, Cancer research.

[11]  M. Girndt,et al.  [The immune defect in kidney failure. II. The mechanisms of the "uremic" immune defect]. , 2008, Deutsche medizinische Wochenschrift.

[12]  H. Slor,et al.  DNA repair and recovery of RNA synthesis in uremic patients. , 1993, Kidney international.

[13]  T. Saruta,et al.  Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients. , 1991, Nephron.